nab-sirolimus

sirolimus (nanoparticle albumin-bound formulation) · Aadi Bioscience, Inc.

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for nab-sirolimus, covering 2023-04-07 to 2026-08-25. Get the full timeline:

Most recent: Clinical Trial Results: Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors [Phase 2]

See pricing